INTERNATIONAL PATENT: TEMPUS AI, INC. FILES APPLICATION FOR "SYSTEMS AND METHODS FOR MOLECULAR RESIDUAL DISEASE LIQUID BIOPSY ASSAY"

GENEVA, April 21 -- TEMPUS AI, INC. (600 West Chicago AvenueSuite 510Chicago, IL 60654) filed a patent application (PCT/US2024/051101) for "SYSTEMS AND METHODS FOR MOLECULAR RESIDUAL DISEASE LIQUID BIOPSY ASSAY" on Oct 11, 2024. With publication no. WO/2025/081081, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE OLAZARRA, Ana, Sofia (C/o Tempus Ai, Inc.600 West Chicago Avenue, Suite 510Chicago, IL 60654), DRIESSEN, Terri, M. (C/o Tempus Ai, Inc.600 West Chicago Avenue, Suite 510Chicago, IL 60654), FOOX, Jon (C/o Tempus...